Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP PILOT STUDY TO EVALUATE THE EFFICACY OF DEXTROMETHORPHAN HYDROBROMIDE ON ACUTE COUGH IN A PEDIATRIC POPULATION

NCT02651116 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02651116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02651116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP PILOT STUDY TO EVALUATE THE EFFICACY OF DEXTROMETHORPHAN HYDROBROMIDE ON ACUTE COUGH IN A PEDIATRIC POPULATION
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
February 25, 2016
Completion date
March 19, 2020
Enrollment
131 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cough